MarketInOut Stock Screener Log In | Sign Up
 

Accuray Inc

IEX • Healthcare • Medical Devices • Quote as of 05/18/2026 15:59
Accuray Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeIEX
Market Capitalization32.12 mln
Float113 mln
Earnings Date08/19/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-2.71
Likely reliable

1-Year Forecast

0.35
Attractive

Relative Strength

1 / 100
Severely lagging

Debt / Equity

4.37
Highly leveraged

ROE

-80.16
Deeply negative

Business Description

Accuray Incorporated designs, manufactures, and sells advanced cancer treatment systems used by hospitals and clinics across North America, Europe, Asia, and beyond. Its two main product lines ? the CyberKnife and TomoTherapy platforms ? allow medical professionals to target tumors throughout the body with a high degree of precision while minimizing damage to surrounding healthy tissue. The company also supports its customers with planning software, data management tools, training, and ongoing technical services. Founded in 1990 and based in Madison, Wisconsin, Accuray sells its products through a mix of direct sales teams, distributors, and purchasing groups worldwide.

Key Fundamentals

EPS-0.38
ROE-80.16
RPS3.67
ROIC-4.41
ROA-10.00
EBITDA, mln-7.72
EV / EBITDA-24.17
EV / EBIT-12.25
Revenue, mln429
EV / Revenue0.44

Financial Strength

Altman Z-Score-0.64
Piotroski F-Score 2 / 9
Beneish M-Score-2.71
Price to Intrinsic Value1.23
1-Year Target Price0.35
Short Ratio5.41
Short % of Float6.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -13.96% 6 / 100   
1 Month -33.72% 2 / 100   
2 Months -48.65% 3 / 100   
6 Months -73.87% 2 / 100   
1 Year -81.59% 2 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us